national-clinical-guidelines-for-stroke-fourth-edition

Contents
The Intercollegiate Stroke Working Party viii
Conflicts of interest x
Preface xi
Key recommendations xii
Acknowledgements xvi
Acronyms and abbreviations xvii
Glossary xviii
1 Introduction 1
1.0 Introduction 1
1.1 Scope 1
1.2 Aims of the guideline 2
1.3 Organisation of the guideline 2
1.3.1 Chapter content 2
1.3.2 Structure of each subject 3
1.4 Definitions 4
1.4.1 Duration of cerebrovascular events 5
1.4.2 Resolved neurovascular events 5
1.5 Context and use 5
1.6 Methodology of guideline development 6
1.6.1 Development of scope 6
1.6.2 Searching the scientific literature 6
1.6.3 Selection of articles for inclusion 7
1.6.4 Assessing the quality of research 7
1.6.5 From evidence to recommendation 7
1.6.6 Strength of recommendation 8
1.6.7 Peer review 8
1.7 Models underlying guideline development 8
1.7.1 Patient interactions – World Health Organization 8
1.8 National Institute for Health and Clinical Excellence guidelines 9
1.9 Participation in clinical research 9
1.10 Cost of stroke care 10
1.11 Licensing of drugs 10
1.12 Updating the guideline 10
1.13 Funding and conflicts of interest 10
Table 1.1 Stroke management: WHO ICF framework and terminology 11
2 Commissioning of stroke services 13
2.0 Introduction 13
2.1 Structure – global cover 14
© Royal College of Physicians 2012 iii